Glycominds
Lod · Founded 1999
About Glycominds
Glycominds, a molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Their proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.
Company Facts
- Founded: 1999
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Last round: Series Unknown (Jan 2005)
- Website: http://www.glycominds.com
- Phone: +1 866.532.5364
Industries & Categories
Biotechnology, Health Diagnostics
Canonical: https://fsome.com/organization/glycominds-3453595 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.